Vanguard Group’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.87M | Buy |
|
|||||
|
2022
Q3 | $2.01M | Hold |
|
|||||
|
2022
Q2 | $2.24M | Hold |
|
|||||
|
2022
Q1 | $4.01M | Buy |
|
|||||
|
2021
Q4 | $6M | Buy |
|
|||||
|
2021
Q3 | $3.55M | Buy |
|
|||||
|
2021
Q2 | $1.83M | Buy |
|
|||||
|
2021
Q1 | $1.2M | Buy |
|
|||||
|
2020
Q4 | $794K | Sell |
|
|||||
|
2020
Q3 | $766K | Sell |
|
|||||
|
2020
Q2 | $960K | Hold |
|
|||||
|
2020
Q1 | $1.02M | Hold |
|
|||||
|
2019
Q4 | $1.53M | Hold |
|
|||||
|
2019
Q3 | $1.65M | Sell |
|
|||||
|
2019
Q2 | $1.65M | Hold |
|
|||||
|
2019
Q1 | $1.64M | Buy |
|
|||||
|
2018
Q4 | $1.78M | Buy |
|
|||||
|
2018
Q3 | $1.88M | Buy |
|
|||||
|
2018
Q2 | $1.2M | Buy |
|
|||||
|
2018
Q1 | $1.55M | Buy |
|
|||||
|
2017
Q4 | $220K | Buy |
|